Recent ATMs

Since 2007, JonesTrading has offered public companies an alternative vehicle for financing and investment banking through direct access to the investor community. JonesTrading believes corporations have been underserved by the offerings currently available.

Recent At-The-Market (ATM) Transactions

Credit Suisse
$150,000,000, CIK-At-the-Market
Sole Sales Agent, November 2021
ARR Armour Residential REIT
25,661,843 shares, At-the-Market
Sales Agent, November 2021
IVR Invesco Mortgage Capital, Inc.
$236,250,000, At-the-Market
Sales Agent, November 2021
ACR Acres Commercial Realty
$2,200,000, Preferred ATM
Sole Sales Agent, October 2021
Aberdeen Asset Management
$35,000,000, FCO-At-the-Market
Sole Sales Agent, September 2021
NYMT New York Mortgage Trust Inc
$100,000,000, Preferred ATM
Sole Sales Agent, August 2021
SURF Surface Oncology
$80,000,000, At-the-Market
Sole Sales Agent, August 2021
INFI Infinity Pharmaceuticals
$75,000,000, At-the-Market
Sales Agent, July 2021
ATAX America First Multifamily Investors, L.P.
$30,000,000, At-the-Market
Sole Sales Agent, July 2021
GEO GEO Group, Inc
$300,000,000, At-the-Market
Sales Agent, June 2021
ORC Orchid Island Capital
$250,000,000, At-the-Market
Sales Agent, June 2021
Western Asset
$43,283,467, DMO-At-the-Market
Sole Sales Agent, May 2021
LIFE aTyr Pharma Inc.
$25,000,000, At-the-Market
Sole Sales Agent, March 2021
CRIS Curis, Inc.
$100,000,000, At-the-Market
Sales Agent, March 2021
ACET Adicet Bio
$75,000,000, At-the-Market
Sole Sales Agent, March 2021
OCUP Ocuphire Pharma
$40,000,000, At-the-Market
Sole Sales Agent, March 2021
ACER Acer Therapeutics
$7,700,000, At-the-Market
Sales Agent, March 2021
CNSP CNS Pharmaceuticals
$20,000,000, At-the-Market
Sales Agent, February 2021
ALRN  Aileron
$30,000,000, At-the-Market
Sales Agent, January 2021
ONVO Organovo Holdings
$50,000,000, January 2021
CMO Capstead
15,000,000 Common
3,000,000 PFD, January 2021
ALRN Aileron
$11,896,613, December 2020
ATHE Alterity Therapeutics
$50,000,000, December 2020
TCON Tracon Pharma
$50,000,000, December 2020
PCN Pimco
$100,000,000 December 2020
PFN Pimco
$175,000,000, November 2020
PFL Pimco
$120,000,000, November 2020
PTY Pimco
$600,000,000, November 2020
PDI Pimco
$600,000,000, November 2020
PCI Pimco
$1,000,000,000, October 2020
PKO Pimco
$125,000,000, October 2020
ATNM Actinium Pharmaceuticals, Inc.
$200,000,000, August 2020
ORC Orchid Island Capital Inc.
$150,000,000, ATM
Sales Agent, August 2020
DX Dynex Capital Inc.
$50,000,000, August 2020
ABIO Arca Biopharma
$54,000,000, July 2020
ABIO Arca Biopharma
$14,910,600, July 2020
OSTK Overstock
$150,000,000, June 2020
SURF Surface Oncology
$50,000,000, May 2020
DMO Western Asset
$50,000,000, April 2020
AGLE Aeglea Biotherapeutics Inc
$60,000,000, April 2020
OSTK Overstock
$80,000,000, April 2020
PFL Pimco
$47,700,000, March 2020
PFN Pimco
$76,800,000, March 2020
ACER Acer Therapeutics
$10,000,000, March 2020
CRIS Curis
$30,000,000, March 2020
TCON Tracon Pharma
$1,983,015, February 2020

PKO Pimco
$125,000,000, January 2020
ORC Orchid Island Capital
$200,000,000, January 2020
MNPR Monopar Therapeutics
$19,700,000, January 2020
PCI Pimco
$1,000,000,000, December 2019
HIE Miller Howard Investments
$50,000,000, December 2019
PTY Pimco
500,000,000, November 2019
PFL Pimco
5,500,000 shares, November 2019
PFN Pimco
11,500,000 shares, November 2019
NYMT New York Mortgage Trust
$100,000,000, November 2019
OSTK Overstock
$150,000,000, November 2019
PDI Pimco
$560,000,000, November 2019
PKO Pimco
3,000,000 shares, October 2019
PTY Pimco
$500,000,000, July 2019
ALRN Aileron
$13,265,506, July 2019
INFI Infinity Pharmaceuticals
$20,000,000, June 2019
FBIO Fortress Biotech
$50,000,000, June 2019
APTS Preferred Apartment Communities
$125,000,000, June 2019
DX Dynex Capital Inc.
25,000,000 shares, May 2019
BPMX BioPharmx
$8,500,000, May 2019
SURF Surface Oncology
$30,000,000, May 2019
NYMT New York Mortgage Trust
$50,000,000, March 2019
AI Arlington Asset Investment Corp
1,647,370 shares, March 2019
IVR Invesco Mortgage Capital Inc.
7,000,000 shares, March 2019
OSTK Overstock
$52,801,423, March 2019
ABIO Arca Biopharma
$2,499,876, January 2019
ATNM Actinium Pharmaceuticals, Inc.
$75,000,000, December 2018
CLSN Celsion Corporation
$16,000,000, December 2018
PTY PIMCO
14,500,000 shares, November 2018
PFL PIMCO
5,500,000 shares, September 2018
PFN PIMCO
11,500,000 shares, September 2018
TCON Tracon Pharmaceuticals
$11,550,332, September 2018
DX Dynex Capital
$50,000,000, September 2018
RIV RiverNorth
3,300,000 shares, August 2018
SDI Standard Diversified
$6,500,000, August 2018
OSTK Overstock
$150,000,000, August 2018
ATAX America First Multifamily Investors, L.P.
$75,000,000, August 2018
PKO Pimco
3,000,000 shares, July 2018
CGO Calamos
2,685,638 shares, June 2018
PTY Pimco
12,500,000 shares, June 2018
ONVO Organovo
$50,000,000, March 2018
FPL First Trust
5,000,000 shares, March 2018
FEI First Trust
4,600,000 shares, March 2018
FEN First Trust
2,800,000 shares, March 2018
HIE Miller Howard
$50,000,000, March 2018
CHY Calamos
6,232,167 shares, March 2018
DHY Credit Suisse
16,690,564 shares, February 2018
PTIE Pain Therapeutics, Inc.
$16,900,000, December 2017
PDI Pimco
9,500,000 shares, December 2017
ATAX America First Multifamily Investors, L.P.
$75,000,000, December 2017
PRAN Prana Biotechnology
$10,019,412, November 2017
HIE Miller Howard
$50,000,000, October 2017
CHY Calamos
6,232,167 shares, October 2017
CHI Calamos
7,500,000 shares, October 2017
ABIO Arca Biopharma
$3,568,486, August 2017
DHY Credit Suisse
20,000,000 shares, July 2017
APTS Preferred Apartment Communities
$150,000,000, July 2017
FPL First Trust
5,000,000 shares, July 2017